Treatments | Disease incidence (%) | Disease protection (%) |
---|---|---|
Control | 98.1m | 0.0a |
B. subtilis SE34 + T. asperellum T8 | 40.3def | 57.8hij |
B. subtilis SE34 + T. harzianum UNS35 | 41.2efgh | 56.9fghi |
B. subtilis SE34 + T. longibrachiatum UNS11 | 42.6jkl | 55.5bcd |
B. subtilis SE34 + T. viride UNS42 | 41.4ghij | 56.7defg |
B. amyloliquefaciens IN937a + T. asperellum T8 | 41.3fghi | 56.8efgh |
B. amyloliquefaciens IN937a + T. harzianum UNS35 | 43.2l | 54.9b |
B. amyloliquefaciens IN937a + T. longibrachiatum UNS11 | 40.2de | 57.9hij |
B. amyloliquefaciens IN937a + T. viride UNS42 | 41.8ghijk | 56.3cdefg |
P. fluorescens Pf3 + T. asperellum T8 | 38.3bc | 59.8kl |
P. fluorescens Pf3 + T. harzianum UNS35 | 38.6bc | 59.5kl |
P. fluorescens Pf3 + T. longibrachiatum UNS11 | 36.2a | 61.9m |
P. fluorescens Pf3 + T. viride UNS42 | 38.8c | 59.3k |